I-131 Omburtamab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for I-131 Omburtamab, covering 2025-07-20 to 2025-07-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum [Phase 2]